2522 Verma et al.
Asian J. Chem.
R1
R2
O
R1
N
R2
R3
N
C
H
R3
NH2
SHCH2COOH
Anhyd. ZnCl2
CH3COOH
+
OHC
S
(III)
R1
(II)
(I)
R2
R3
IV
R1 = R24 = NO2, OCH3; R3 = R25 = OCH3, OC2H5, Cl, OH, (CH3)2-N-; R4 = OCH3
Fig. 1
(s, 1H, CH-benzene), 8.1 (s, 1H, CH-benzene). IR (KBr, νmax
,
cyclic), 668-602 (C-S-C), 1140 (CO- cyclic), M+1 Peak-
345.50.
2-(3,4-Dimethoxyphenyl)-3-(naphthalene-1-yl)thia-
zolidin-4-one (1e): m.f.: C22H23NO2S, yield: 43 %, PMR (CDCl3,
δ in ppm): 3.6 (s, 1H, -CH-thiazolidine ring), 5.8 (m, 1H, -CH-
thiazolidine ring), 7.15 (s, 2H, -CH2-naphthalene ring), 7.23 (s,
cm-1): 1724 (CO- cyclic), 2950 (CH2-S- cyclic), 1680 (CON-
cyclic), 668-602 (C-S-C), 1140 (CO- cyclic), M+1 Peak-
360.30.
2-(4-Hydroxyphenyl)-3-(naphthalene-1-yl)thiazolidin-
4-one (1b): m.f.: C19H15NO2S, yield: 43 %, PMR (CDCl3,δ in
ppm): 3.6 (s, 1H, -CH-thiazolidine ring), 5.8 (m, 1H, -CH-
thiazolidine ring), 7.15 (s, 2H, -CH2-naphthalene ring), 7.23
1H, CH-benzene), 3.71 (s, 3H-, CH3-benzene). IR (KBr, νmax
,
cm-1): 1724 (CO- cyclic), 2950 (CH2-S- cyclic), 1680 (CON-
cyclic), 668-602 (C-S-C), 1140 (CO- cyclic), M+1 Peak- 375.49.
2-(4-Chlorophenyl)-3-(naphthalene-1-yl)thiazolidin-4-
one (1f): m.f.: C19H14NOSCl, yield: 43 %, PMR (CDCl3, δ
in ppm): 3.6 (s, 1H, -CH-thiazolidine ring), 5.8 (m, 1H, -CH-
thiazolidine ring), 7.15 (s, 2H, -CH2-naphthalene ring), 7.23
(s, 1H- benzene). IR (KBr, νmax, cm-1): 1724 (CO- cyclic), 2950
(CH2-S- cyclic), 1680 (CON- cyclic), 668-602 (C-S-C), 1140
(CO- cyclic), M+1 Peak- 349.50.
(s, 1H, CH-benzene), 5.8 (s, 1H- OH-benzene). IR (KBr, νmax
,
cm-1): 1724 (CO- cyclic), 2950 (CH2-S- cyclic), 1680 (CON-
cyclic), 668-602 (C-S-C), 1140 (CO- cyclic), M+1 Peak-
331.39.
2-(4-Dimethylaminophenyl)-3-(naphthalene-1-yl)-
thiazolidin-4-one (1c): m.f.: C21H20N2OS, yield: 43 %, PMR
(CDCl3, δ in ppm): 3.6 (s, 1H, -CH-thiazolidine ring), 5.8 (m,
1H, -CH-thiazolidine ring), 7.15 (s, 2H, -CH2-naphthalene
ring), 7.23 (s, 1H, CH-benzene), 2.78 (s, 3H- CH3-benzene).
IR (KBr, νmax, cm-1): 1724 (CO- cyclic), 2950 (CH2-S- cyclic),
1680 (CON- cyclic), 668-602 (C-S-C), 1140 (CO- cyclic), M+1
Peak- 359.50.
2-(4-Methoxyphenyl)-3-(naphthalene-1-yl)thiazolidin-
4-one (1d): m.f.: C20-H17NO2S yield: 43 %, PMR (CDCl3,δ in
ppm): 3.6 (s, 1H, -CH-thiazolidine ring), 5.8 (m, 1H, -CH-
thiazolidine ring), 7.15 (s, 2H, -CH2-naphthalene ring), 7.23 (s,
Evaluation of antimicrobial activity: Antimicrobial
activity of the 4-thiazolidinone derivatives were determined by
cup plate method [8] using bacterial strains such as Staphylococcus
aureus, Escherichia coli, Pseudomonas aeurginosa and Bacillus
subtilis and antifungal activity against fungal strain of Candida
albicans [9,10]. Antibiotic ofloxacin was used as standard drug
for determination of antimicrobial activity at concentration of
100 µg/mL [11] and econazole was used as standard drug for
determination of antifungal activity at concentration of 100
µg/mL [12] (Table-1).
1H, CH-benzene), 3.68 (s, 3H- CH3-benzene). IR (KBr, νmax
,
cm-1): 1724 (CO- cyclic), 2950 (CH2-S- cyclic), 1680 (CON-
TABLE-1
ANTIMICROBIAL ACTIVITY OF 4-THIAZOLIDINONE DERIVATIVES
Diameters (mm) of zones of inhibition for microorganism
Compound
Conc. (µg/mL)
100
B. subtilis
15.7
NA
S. aureus
15.5
NA
E. coli
15.7
NA
7.5
P. aeurginosa
15.7
NA
C. albicans
Ofloxacin
Econazole
NA
16.5 0.1
100
100
8.6
7.9
8.5
–
–
–
–
–
–
–
–
–
–
–
–
1a
1b
1c
1d
1e
1f
150
100
150
100
150
100
150
100
12.8
5.2
9.6
9.6
12.8
8.6
14.5
6.7
11.5
5.8
13.3
6.5
4.9
9.2
15.9
7.9
15.7
5.7
10.2
5.7
12.7
4.7
7.9
8.5
15.8
7.5
15.5
5.4
11.4
5.2
12.7
5.3
9.7
9.7
16
8.5
15.1
5.9
15.8
5.9
4.8
150
100
150
10.5
10.2
10.5
*Zone of inhibition were measured as average of triplet; Highly active = Inhibition zone > 12 mm; Moderately active = Inhibition zone 6-12 mm;
Slightly active = Inhibition zone < 6 mm; Not active (NA) = Indicate no zone of inhibition.